Infected wounds caused
by persistent inflammation exhibit poor
vascularization and cellular infiltration. In order to rapidly control
the inflammatory effect and accelerate wound healing, it is necessary
to develop a novel drug vehicle addressing the need for infected wounds.
Herein, we developed a novel dual-drug delivery system with micrometer-scale
alginate fibers encapsulated in instant self-assembly peptide hydrogel.
Short peptides with the sequence of Nap-Gly-Phe-Phe-Lys-His (Nap-GFFKH)
could self-assemble outside the microfluidic-based alginate microfibers
in weak acidic solution (pH ≈ 6.0) within 5 s. The gelation
condition is close to the pH environment of the human skin. We further
constructed recombinant bovine basic fibroblast growth factor (FGF-2)
in fibrous alginate, which was encapsulated in antibiotic-loaded peptide
hydrogel. The dual-drug delivery system exhibited good mechanical
property and sustained release profiles, where antibiotic could be
rapidly released from the peptide hydrogel, while the growth factor
could be gradually released within 7 days. Both in vitro antibacterial experiments and in vivo animal experiments
confirmed that such a dual-drug delivery system has good antibacterial
activity and enhances wound healing property. We suggested that the
dual-drug delivery system could be potentially applied for controlled
drug release in infected wound healing, drug combination for melanoma
therapy, and tissue engineering.